4/17
01:22 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
4/17
01:22 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
3/27
08:07 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
3/27
08:07 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "neutral" rating re-affirmed by analysts at Guggenheim.
3/27
06:47 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
3/27
06:47 am
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
3/18
03:15 pm
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
Low
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.00 price target on the stock.
2/16
01:44 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
2/16
01:44 pm
tvtx
Rating for TVTX
Low
Report
Rating for TVTX
2/16
09:21 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
Medium
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
2/16
09:21 am
tvtx
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
Medium
Report
Travere Therapeutics, Inc. (NASDAQ: TVTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $13.00 price target on the stock.
2/16
08:56 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX
2/16
08:56 am
tvtx
Rating for TVTX
Medium
Report
Rating for TVTX